해당없음모집 예정

Clostridioides Difficile Controlled Human Infection Model

연구 개요

This study will investigate in healthy study subjects, the safety and tolerability of a controlled infection with Clostridioides difficile, a gut bacterium that can cause diarrhoea. It is also examined which dosing regimen (with or without antibiotic pretreatment) is required to induce mild symptoms (like diarrhoea) in the majority of study subjects and which microbiota and immunological factors influence this. To investigate this, healthy adult study subjects will be asked to ingest capsules (pills) containing the Clostridioides bacterium.

스폰서
협력: GSK
적응증
C. Difficile, C. Difficile Infection, Controlled Human Infection
중재
encapsulated 10^4 CFU toxigenic. C. difficile spores, Vancomycin, Clindamycin
목표 등록
60
시작일
2025-03-01
완료(예정)
2026-12-31

BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.